HUMDF (Hua Medicine) EV-to-Revenue : 10.13 (As of Jul. 16, 2025)

View and export this data going back to 2018. Start your Free Trial

What is Hua Medicine EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Hua Medicine's enterprise value is $356.55 Mil. Hua Medicine's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $35.20 Mil. Therefore, Hua Medicine's EV-to-Revenue for today is 10.13.

The historical rank and industry rank for Hua Medicine's EV-to-Revenue or its related term are showing as below:

HUMDF' s EV-to-Revenue Range Over the Past 10 Years
Min: -3.47 Med: 5.16 Max: 220.66
Current: 10.21

During the past 9 years, the highest EV-to-Revenue of Hua Medicine was 220.66. The lowest was -3.47. And the median was 5.16.

HUMDF's EV-to-Revenue is ranked worse than
86.56% of 967 companies
in the Drug Manufacturers industry
Industry Median: 2.51 vs HUMDF: 10.21

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-07-16), Hua Medicine's stock price is $0.4107. Hua Medicine's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $0.04. Therefore, Hua Medicine's PS Ratio for today is 11.73.

Hua Medicine EV-to-Revenue Historical Data

The historical data trend for Hua Medicine's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hua Medicine EV-to-Revenue Chart

Hua Medicine Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-Revenue

Get a 7-Day Free Trial

162.28

6.17

1.90

Hua Medicine Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-Revenue	Get a 7-Day Free Trial												162.28	-	6.17	-	1.90

Competitive Comparison of Hua Medicine's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Hua Medicine's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hua Medicine's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hua Medicine's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hua Medicine's EV-to-Revenue falls into.

Save Embed

;

Save Embed

;

Hua Medicine EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Hua Medicine's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	356.546	/	35.197
	=	10.13

Hua Medicine's current Enterprise Value is $356.55 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hua Medicine's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $35.20 Mil.

Hua Medicine (OTCPK:HUMDF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Hua Medicine's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.4107	/	0.035
	=	11.73

Hua Medicine's share price for today is $0.4107.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was $0.04.

Hua Medicine EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hua Medicine's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hua Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hua Medicine (OTCPK:HUMDF) » Definitions » EV-to-Revenue

Traded in Other Exchanges

02552:Hong Kong

Address

Lane 36, Xuelin Road, Hua Medicine, Building 2, Pudong New Area, Shanghai, CHN, 201203

Website

https://www.huamedicine.com

Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin or HMS5552, for the treatment of Type 2 diabetes. Dorzagliatin is a first-in-class glucokinase activator, or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The group majorly operates and generates the majority of its revenue from PRC.